Workbook for Rau's Respiratory Care Pharmacology - Elsevier eBook on Vitalsource (Retail Access Card) - Gardenhire, Douglas S.; Hinski, Sandra T.
33,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
17 °P sammeln
  • Gebundenes Buch

Take an easier path to respiratory pharmacology mastery. Workbook for Rau's Respiratory Care Pharmacology, 11th Edition features a variety of engaging learning exercises for each of the 22 chapters in the core text. Examples include NBRC(R)-type questions, critical-thinking exercises, case studies, definitions, and additional content review to further your understanding of challenging pharmacology principles, develop your critical-thinking skills, and prepare you for success on the board exam. Thoroughly revised and updated, the Rau's workbook is part of the complete learning package for your…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Take an easier path to respiratory pharmacology mastery. Workbook for Rau's Respiratory Care Pharmacology, 11th Edition features a variety of engaging learning exercises for each of the 22 chapters in the core text. Examples include NBRC(R)-type questions, critical-thinking exercises, case studies, definitions, and additional content review to further your understanding of challenging pharmacology principles, develop your critical-thinking skills, and prepare you for success on the board exam. Thoroughly revised and updated, the Rau's workbook is part of the complete learning package for your continued success! * Answers reference back to the objectives in the core text to help you easily review your areas of weakness. * Case studies and critical-thinking questions promote the application of clinical skills. * Key illustrations from the text provide a visual review to enhance your study of important concepts. * Engaging pharmacology exercises reinforce foundational content, such as key terms and definitions. * NEW! Updated content reflects changes to drug approval, aerosol medication devices and associated issues related to COVID-19, FDA-approved medications, and asthma and COPD treatment protocols.